- Home
- STRM vs BCTX Comparison
STRM vs BCTX Comparison
Compare STRM & BCTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STRM
- BCTX
- Stock Information
- Founded
- STRM 1989
- BCTX 2014
- Country
- STRM United States
- BCTX Canada
- Employees
- STRM N/A
- BCTX N/A
- Industry
- STRM EDP Services
- BCTX Biotechnology: Pharmaceutical Preparations
- Sector
- STRM Technology
- BCTX Health Care
- Exchange
- STRM Nasdaq
- BCTX Nasdaq
- Market Cap
- STRM 15.4M
- BCTX 16.1M
- IPO Year
- STRM 1996
- BCTX N/A
- Fundamental
- Price
- STRM $2.66
- BCTX $3.18
- Analyst Decision
- STRM
- BCTX Strong Buy
- Analyst Count
- STRM 0
- BCTX 1
- Target Price
- STRM N/A
- BCTX $32.00
- AVG Volume (30 Days)
- STRM 5.9K
- BCTX 3.7M
- Earning Date
- STRM 06-10-2025
- BCTX 06-13-2025
- Dividend Yield
- STRM N/A
- BCTX N/A
- EPS Growth
- STRM N/A
- BCTX N/A
- EPS
- STRM N/A
- BCTX N/A
- Revenue
- STRM $17,901,000.00
- BCTX N/A
- Revenue This Year
- STRM N/A
- BCTX N/A
- Revenue Next Year
- STRM $4.04
- BCTX N/A
- P/E Ratio
- STRM N/A
- BCTX N/A
- Revenue Growth
- STRM N/A
- BCTX N/A
- 52 Week Low
- STRM $1.82
- BCTX $0.35
- 52 Week High
- STRM $9.75
- BCTX $9.82
- Technical
- Relative Strength Index (RSI)
- STRM 46.47
- BCTX 37.13
- Support Level
- STRM $2.70
- BCTX $4.04
- Resistance Level
- STRM $3.40
- BCTX $9.82
- Average True Range (ATR)
- STRM 0.28
- BCTX 0.75
- MACD
- STRM 0.02
- BCTX -0.22
- Stochastic Oscillator
- STRM 37.75
- BCTX 1.34
About STRM Streamline Health Solutions Inc.
Streamline Health Solutions Inc provides transformational data-driven solutions for healthcare organizations. It provides computer software-based solutions through its looking glass platform. Its solutions include coding and CDI, coding audit, and financial management solutions. It offers various services, such as custom integration services, training services, electronic image conversion and database monitoring services. It sells its solutions and services in North America to hospitals and health systems, including physician practices, through its direct sales force and its reseller partnerships.
About BCTX BriaCell Therapeutics Corp.
BriaCell Therapeutics Corp is a clinical-stage immuno-oncology company. The group is developing an entirely new class of targeted immunotherapies to transform cancer care. Its product candidate Bria-IMT, is being evaluated in a pivotal Phase 3 combination study for metastatic breast cancer (MBC is breast cancer that has spread to other tissues). Bria-IMT is a targeted cell-based immunotherapy. The company is engaged in developing a Bria-OTS platform of personalized off-the-shelf cell-based immunotherapies. It is being evaluated in a Phase 1/2 clinical study and the treatment is initially focused on patients with breast cancer with an extension to prostate cancer, and other cancers.